We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Boston Scientific to Pay $716 Mill. to J&J in Legal Settlement

By HospiMedica International staff writers
Posted on 02 Oct 2009
In a multimillion-dollar settlement, Boston Scientific (Natick, MA, USA) has agreed to compensate Johnson & Johnson (J&J; New Brunswick, NJ, USA) over patent claims.

The announced settlement, amounting to US$716 million, substantially resolves Boston Scientific's legal obligation to J&J after 12 years of lawsuits over conflicting patent claims about stents used in interventional cardiology. More...
The settlement resolves 14 lawsuits between the two companies, with possibly 3 more lawsuits remaining unsettled. The settlement also includes patents and cross-licenses between the companies.

Also pending is a court win in which Boston Scientific was favored in a patent verdict against J&J. The amount of the judgment, however, is not known at this time.

Major stent manufacturers, among them Abbott and Medtronic, have filed patent lawsuits against each other, some of which have been settled to date. Earlier in 2009, Boston Scientific has also settled a patent claim lawsuit with Medtronic.

Boston Scientific leads the stent market with $4 billion in annual sales.

Related Links:
Boston Scientific
Johnson and Johnson



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.